Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GTF2A2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LRRD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HACD2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GBE1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FBXO45 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TFRC - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC61A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SLC31A1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEL1L - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
WLS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RNF103 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMED3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PDK1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
COPG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SQLE - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM173 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GRB14 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SPATA5L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TLE3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on